Numbers
CTRC members
0
152
Projects
0
25
Institutions
0
68
Cities
0
22
Projects
Read more
Novel Neuroimaging Approaches to Diagnose Sport-Related Concussion and Inform “Return to Play”
Mild traumatic brain injury (mTBI), including sport-related concussion, has become a major health issue. Nearly 10% of mTBI patients (aged...
Read more
Mild Injury Outcomes Study (MIOS)
A critical decision confronting health care providers is how to predict in the acute setting which children will suffer persistent...
Read more
The NeurO2 Study: Optimal Brain Oxygenation in Neurocritically Ill Patients
THE PROBLEM Traumatic brain injury (TBI) and aneurysmal subarachnoid hemorrhage (aSAH) are devastating neurologic events that represent the majority of...
Mild traumatic brain injury (mTBI), including sport-related concussion, has become a major health issue. Nearly 10% of mTBI patients (aged 0-18 years) are symptomatic with post-concussion syndrome (PCS) three months after injury. Persistent post-concussion symptoms often result in significant disability and family burden. However, the biological explanation for these prolonged PCS symptoms remains unclear.
A critical decision confronting health care providers is how to predict in the acute setting which children will suffer persistent postconcussive symptoms (PCS) and functional impairments after mild traumatic brain injury (TBI).
Traumatic brain injury (TBI) and aneurysmal subarachnoid hemorrhage (aSAH) are devastating neurologic events...
Members
Participating institutions
News
July 2, 2022
Meetings
First announcement: 14th CTRC Scientific Meeting January 2023
Our January 2023 meeting will be held in Lake Louise (AB)...
May 10, 2022
Award, Meetings
Travel awards for June 2022
Five trainees are offered a Travel award in support of travel to attend next CTRC Spring Meeting in Montréal June...
March 9, 2022
Meetings
13th CTRC Scientific Meeting, Spring 2022
June 2-4, 2022, in Montreal (QC)
January 20, 2022
Articles
Recently published
Blood-based TBI biomarkers – Clinical utilities and regulatory pathways in the USA, Europe and Canada